Fidelis Insurance (NYSE:FIHL) Stock Price Expected to Rise, Barclays Analyst Says

Key Points

• Barclays raised its price target on Fidelis Insurance to $21 from $19 (implying ~7.4% upside); analysts' average target is $22.64 and ratings are mixed (5 Buy, 3 Hold, 2 Sell), leaving an overall "Hold" consensus.
• Fidelis beat quarterly EPS estimates ($1.09 vs. $0.96) but missed revenue expectations ($600.9M vs. $756.1M), and the board authorized a $400 million share buyback to repurchase up to 18% of outstanding shares.
• Shares traded near $19.55 (52‑week range $14.80–$20.50), the company has a PE of 8.84 and a market cap of about $1.89B, and institutional investors own roughly 82% of the stock.

Fidelis Insurance (NYSE:FIHL - Get Free Report) had its target price hoisted by investment analysts at Barclays from $19.00 to $21.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's price objective would indicate a potential upside of 7.44% from the stock's previous close.

Several other research analysts also recently weighed in on FIHL. Evercore set a $21.00 price target on shares of Fidelis Insurance in a research report on Wednesday, January 7th. Weiss Ratings upgraded shares of Fidelis Insurance from a "hold (c)" rating to a "buy (b)" rating in a research report on Friday, March 6th. JPMorgan Chase & Co. reaffirmed an "underweight" rating and issued a $21.00 price objective (up from $19.00) on shares of Fidelis Insurance in a research note on Wednesday, January 7th. Keefe, Bruyette & Woods raised their price objective on Fidelis Insurance from $24.00 to $26.00 and gave the stock an "outperform" rating in a research note on Monday, February 23rd. Finally, UBS Group raised their price objective on Fidelis Insurance from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Monday, March 9th. Five analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $22.64.

Fidelis Insurance Stock Performance

FIHL stock traded up $0.34 during trading on Wednesday, reaching $19.55. The stock had a trading volume of 85,839 shares, compared to its average volume of 429,129. Fidelis Insurance has a 52 week low of $14.80 and a 52 week high of $20.50. The stock's 50 day moving average is $19.23 and its two-hundred day moving average is $18.83. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.35. The firm has a market cap of $1.89 billion, a PE ratio of 8.84 and a beta of 0.23.

Fidelis Insurance (NYSE:FIHL - Get Free Report) last posted its earnings results on Thursday, February 26th. The company reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.13. Fidelis Insurance had a return on equity of 8.62% and a net margin of 9.02%.The company had revenue of $600.90 million for the quarter, compared to the consensus estimate of $756.14 million. As a group, equities analysts anticipate that Fidelis Insurance will post 3.12 earnings per share for the current year.

Fidelis Insurance announced that its Board of Directors has initiated a stock repurchase plan on Friday, February 20th that allows the company to buyback $400.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 18% of its shares through open market purchases. Shares buyback plans are often a sign that the company's management believes its shares are undervalued.

Institutional Trading of Fidelis Insurance

Several hedge funds have recently bought and sold shares of FIHL. Royce & Associates LP lifted its stake in Fidelis Insurance by 2,333.5% in the 3rd quarter. Royce & Associates LP now owns 1,591,259 shares of the company's stock worth $28,881,000 after purchasing an additional 1,525,868 shares in the last quarter. LSV Asset Management lifted its stake in Fidelis Insurance by 46.1% in the 4th quarter. LSV Asset Management now owns 4,377,732 shares of the company's stock worth $85,672,000 after purchasing an additional 1,382,352 shares in the last quarter. Cooperman Leon G increased its stake in Fidelis Insurance by 14.8% in the 3rd quarter. Cooperman Leon G now owns 6,662,469 shares of the company's stock worth $120,924,000 after acquiring an additional 856,413 shares during the last quarter. Millennium Management LLC increased its stake in Fidelis Insurance by 113.9% in the 3rd quarter. Millennium Management LLC now owns 924,380 shares of the company's stock worth $16,777,000 after acquiring an additional 492,253 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Fidelis Insurance by 108.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 729,818 shares of the company's stock worth $14,283,000 after acquiring an additional 380,352 shares during the last quarter. Hedge funds and other institutional investors own 81.99% of the company's stock.

Fidelis Insurance Company Profile

Fidelis Insurance Holdings Ltd is a Bermuda‐incorporated specialty insurer and reinsurer that underwrites a broad range of liability and property risks. Founded in 2015, the company completed its initial public offering on the New York Stock Exchange in 2016 under the ticker FIHL. Fidelis focuses on providing tailored solutions for complex risks that traditional insurers may find difficult to accommodate, leveraging data analytics and underwriting expertise to structure policies across diverse industry segments.

The company’s product portfolio spans casualty lines—including general liability, excess and umbrella, professional indemnity, and management liability—alongside property, marine, energy and specialty programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.